Zheng Quan Zhi Xing·2025-06-05 13:47Core Viewpoint - The announcement details a change in the equity holdings of major shareholders in Junshi Biosciences, with a decrease in their combined shareholding from 9.73% to 8.96% due to various factors, including liquidity arrangements [1][3]. Group 1: Shareholder Information - The major shareholder, Shanghai Tanying Investment Partnership, along with its concerted parties, has reduced its shareholding [1]. - The total number of shares held by these shareholders decreased from 95,907,223 shares to 88,338,379 shares [3]. - The change in shareholding does not trigger mandatory tender offer obligations [1]. Group 2: Shareholding Breakdown - Shanghai Tanying's shares decreased from 75,076,239 shares (7.62%) to 71,459,326 shares (7.25%) [3]. - Shanghai Tanzheng's shares decreased from 1,591,971 shares (0.16%) to 0 shares [3]. - LVC Fund II's shares decreased from 1,132,301 shares (1.15%) to 896,305 shares (0.91%) [3]. Group 3: Additional Notes - The equity change does not affect the control of the company or its major shareholders [3]. - The change does not require the disclosure of an equity change report [3].